Two series of 4-(4-methoxybenzyl)phthalazines 4a-j & 7a-i were synthesized.
The prepared phthalazines were evaluated for their inhibitory activity against VEGFR-2.
Molecular docking was used to improve the binding affinity for 4a–j towards VEGFR-2.
7g–i inhibited VEGFR-2 with IC50 = 0.086, 0.083 and 0.086 μM, respectively.
Anticancer activity of the synthesized compounds was screened by the (NCI), USA.